[图书][B] WHO guidelines for screening and treatment of precancerous lesions for cervical cancer prevention
World Health Organization - 2021 - books.google.com
This WHO and HRP guideline is designed to help countries make faster progress, more
equitably, on the screening and treatment of cervical cancer. It includes some important …
equitably, on the screening and treatment of cervical cancer. It includes some important …
Impact of scaled up human papillomavirus vaccination and cervical screening and the potential for global elimination of cervical cancer in 181 countries, 2020–99: a …
Background Cervical screening and human papillomavirus (HPV) vaccination have been
implemented in most high-income countries; however, coverage is low in low-income and …
implemented in most high-income countries; however, coverage is low in low-income and …
Benefits, harms and cost-effectiveness of cervical screening, triage and treatment strategies for women in the general population
Abstract In 2020, the World Health Organization (WHO) launched a strategy to eliminate
cervical cancer as a public health problem. To support the strategy, the WHO published …
cervical cancer as a public health problem. To support the strategy, the WHO published …
[HTML][HTML] Impact of HPV vaccine hesitancy on cervical cancer in Japan: a modelling study
Background Funding for human papillomavirus (HPV) vaccination in Japan began in 2010
for girls aged 12–16 years, with three-dose coverage initially reaching more than 70%. On …
for girls aged 12–16 years, with three-dose coverage initially reaching more than 70%. On …
Primary HPV testing versus cytology-based cervical screening in women in Australia vaccinated for HPV and unvaccinated: effectiveness and economic assessment …
Summary Background Australia's National Cervical Screening Program currently
recommends cytological screening every 2 years for women aged 18–69 years. Human …
recommends cytological screening every 2 years for women aged 18–69 years. Human …
Projected time to elimination of cervical cancer in the USA: a comparative modelling study
Summary Background In May, 2018, the Director-General of WHO issued a global call to
eliminate cervical cancer as a public health problem, which will involve ambitious screening …
eliminate cervical cancer as a public health problem, which will involve ambitious screening …
Benefits and harms of cervical screening, triage and treatment strategies in women living with HIV
To support a strategy to eliminate cervical cancer as a public health problem, the World
Health Organisation (WHO) reviewed its guidelines for screening and treatment of cervical …
Health Organisation (WHO) reviewed its guidelines for screening and treatment of cervical …
[HTML][HTML] Overcoming barriers in HPV vaccination and screening programs
Abstract The Human Papillomavirus Prevention and Control Board brought together experts
to discuss optimizing HPV vaccination and screening programs. Board members reviewed …
to discuss optimizing HPV vaccination and screening programs. Board members reviewed …
Projected future impact of HPV vaccination and primary HPV screening on cervical cancer rates from 2017–2035: example from Australia
Background Many countries are transitioning from cytology-based to longer-interval HPV
screening. Trials comparing HPV-based screening to cytology report an increase in CIN2/3 …
screening. Trials comparing HPV-based screening to cytology report an increase in CIN2/3 …
[HTML][HTML] HPV-FRAME: A consensus statement and quality framework for modelled evaluations of HPV-related cancer control
K Canfell, JJ Kim, S Kulasingam, J Berkhof… - Papillomavirus …, 2019 - Elsevier
Intense research activity in HPV modelling over this decade has prompted the development
of additional guidelines to those for general modelling. A specific framework is required to …
of additional guidelines to those for general modelling. A specific framework is required to …